Fny Investment Advisers, LLC Mustang Bio, Inc. Transaction History

Fny Investment Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 14, 2021	SELL	$2.7 - $3.81 $540,000 - $762,000	-200,000 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$2.66 - $4.18 $266,000 - $418,000	-100,000 Reduced 33.33%	200,000 $757,000
Q3 2020 Oct 09, 2020	BUY	$3.01 - $3.88 $150,500 - $194,000	50,000 Added 20.0%	300,000 $945,000
Q2 2020 Jul 10, 2020	BUY	$2.33 - $4.6 $116,500 - $229,999	50,000 Added 25.0%	250,000 $795,000
Q1 2020 Apr 09, 2020	BUY	$1.91 - $4.52 $133,700 - $316,399	70,000 Added 53.85%	200,000 $536,000
Q4 2019 Jan 10, 2020	BUY	$2.57 - $4.08 $77,100 - $122,400	30,000 Added 30.0%	130,000 $530,000
Q3 2019 Oct 25, 2019	SELL	$2.74 - $4.65 $274,000 - $465,000	-100,000 Reduced 50.0%	100,000 $326,000
Q2 2019 Jul 24, 2019	BUY	$2.66 - $6.28 $532,000 - $1.26 Million	200,000 New	200,000 $736,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.